It's simple, imo trust and credibility remain the big
It's simple, imo trust and credibility remain the big issues for support. Joe's vision/business plan , missed targets and funding/lawsuits increase the risk for any institution to participate. Investing in Management and potential has turned into SHOW ME ......the result is lack of funding, lawsuits and ongoing dilution. If the transition of IP has started the China deal will turn quiet and potential revenues questionable............in addition other investors may not see the big value for future research. Big pharma doesn't wait around for NGIO .......they will provide boosters if necessary. ......no big deal for people to stop by CVS, Walgreens etc to get another shot......5 min, and supplies will be a non issue in 6-12 months.
No info on core business or revenue and the blah blah blah goes on and on. Joe had his chance and should resign unless his ego can't handle it.....the BOD needs to step up.
Since late 2018 we have been talking about Nasdaq ........HIGH PRIORITY !! Due-diligence answers any questions, as far as "World Class Management " .......you decide. The Scientific Board may have qualified people but they don't decide on the direction of the company. We need a seasoned reputable leader to restore trust/credibility and results. A little success won't erase the past ..........
Don't expect a huge IPO if Dawson James is still on board, and what is the plan when funds become available.......dump it in the "business plan" ....run out and start dilution allover .......it will take time to generate revenue .........
Altucell still around? Without any transparency and truthful updates any assumptions is valid until proven inaccurate!!
4
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Meta Platforms in the Media Landscape In today's dynamic business environment, a thorough evaluation of company performance is pivotal for investors and industry analysts alike. This article aims to provide a comprehensive comparative analysis of Meta Platforms (NASDAQ: META) alongside its main competitors within the Interactive Media & Services sector. By...
Continue Reading
Performance Shipping Inc. Schedules Annual General Meeting ATHENS, Greece, Performance Shipping Inc. (NASDAQ: PSHG), a leading name in the shipping industry, is making strides in its operational calendar by announcing the date for its upcoming annual general meeting of shareholders. This meeting is a pivotal occasion for shareholders as it allows for discussion on company...
Continue Reading
Health Net Offers Comprehensive Assistance to Members In response to the urgent needs following the Franklin Fire in Malibu Canyon, Health Net is stepping up to provide essential support to its members and healthcare providers. This action comes as part of a broader commitment to the community during times of crisis. With a long-standing reputation in Medi-Cal managed...
Continue Reading
Understanding Prepayments Prepayments are an essential aspect of financial operations that allow borrowers to pay off loans earlier than scheduled, impacting both lenders and investors. Nykredit Realkredit A/S recognizes the importance of keeping its stakeholders informed about such developments, especially concerning its bond issuances. This article delves into the...
Continue Reading
Nucleic Acid Isolation and Purification Market Overview The nucleic acid isolation and purification market is witnessing remarkable growth, projected to soar from approximately USD 7.10 billion in 2025 to USD 10.99 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.1%. This surge is largely fueled by the escalating adoption of next-generation sequencing...
Continue Reading